Shenzhen Neptunus Interlong Bio-Technique Co Ltd (8329):企業の財務・戦略的SWOT分析

◆英語タイトル:Shenzhen Neptunus Interlong Bio-Technique Co Ltd (8329) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH180702FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥78,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥117,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shenzhen Neptunus Interlong Bio-Technique Co Ltd (Neptunus) manufactures and distributes gene engineering drugs and preventive biological products. The company’s products include recombinant human interferon a-2b injection, used to treat hepatitis and cancers; recombinant human interleukin-2, an injection developed for killing cancer cells by increasing the growth of T lymphocytes and B lymphocytes; and subunit influenza vaccine. It also conducts research for developing cytokines products and vaccines. The company markets its products across China. Neptunus is headquartered in Shenzhen, China.

Shenzhen Neptunus Interlong Bio-Technique Co Ltd Key Recent Developments

Feb 26,2021: Shenzhen Neptunus Interlong Bio-technique Company : appointment of non-executive Director

This comprehensive SWOT profile of Shenzhen Neptunus Interlong Bio-Technique Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Shenzhen Neptunus Interlong Bio-Technique Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Key Information
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Overview
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Key Employees
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Key Employee Biographies
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Key Operational Heads
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Major Products and Services
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – History
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Company Statement
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Locations And Subsidiaries
Shenzhen Neptunus Interlong Bio-Technique Co Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Business Description
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Corporate Strategy
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Strengths
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Weaknesses
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Opportunities
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Threats
Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Shenzhen Neptunus Interlong Bio-Technique Co Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Key Information
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Key Ratios
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Share Data
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Major Products and Services
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, History
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Key Employees
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Key Employee Biographies
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Key Operational Heads
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Other Locations
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Subsidiaries
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Key Competitors
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, SWOT Analysis
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Ratios based on current share price
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Annual Ratios
Shenzhen Neptunus Interlong Bio-Technique Co Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Shenzhen Neptunus Interlong Bio-Technique Co Ltd (8329):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Servair:企業の戦略・SWOT・財務分析
    Servair - Strategy, SWOT and Corporate Finance Report Summary Servair - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Mendor Oy-医療機器分野:企業M&A・提携分析
    Summary Mendor Oy (Mendor) is a medical equipment company that designs, develops and markets advanced diabetes management products. The company’s products include portable blood glucose meter and web-based software application for the daily management of diabetes. It offers blood glucose meter mendo …
  • Schweitzer-Mauduit International Inc (SWM):企業の財務・戦略的SWOT分析
    Schweitzer-Mauduit International Inc (SWM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Materialise NV (MTLS):企業の財務・戦略的SWOT分析
    Materialise NV (MTLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Medizone International Inc (MZEI):企業の財務・戦略的SWOT分析
    Summary Medizone International Inc (Medizone) is a medical device company that develops aseptic treatment. The company provides disinfectant products used in surgical and other medical treatment facilities. Its product includes AsepticSure hospital sterilization system. Medizone’s AsepticSure is an …
  • Phosphagenics Ltd:企業の戦略・SWOT・財務情報
    Phosphagenics Ltd - Strategy, SWOT and Corporate Finance Report Summary Phosphagenics Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Carrabba’s Italian Grill, Inc.:企業の戦略・SWOT・財務情報
    Carrabba's Italian Grill, Inc. - Strategy, SWOT and Corporate Finance Report Summary Carrabba's Italian Grill, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Dil Ltd (506414):企業の財務・戦略的SWOT分析
    Summary Dil Ltd (Dil), formerly Duphar-Interfran Ltd, is a developer of medicinal and pharmaceutical products. The company offers products in the areas such as biotechnology, environmental solutions, pharmaceuticals, and vitamins. It also offers services such as health and wellness, entertainment, e …
  • SCHOTT AG:企業の戦略・SWOT・財務情報
    SCHOTT AG - Strategy, SWOT and Corporate Finance Report Summary SCHOTT AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • AB Science SA (AB):製薬・医療:M&Aディール及び事業提携情報
    Summary AB Science SA (ABS) is a pharmaceutical company focused on discovery, development, and commercialization of protein kinase inhibitors. The company's lead compound Masitinib, is a orally administered tyrosine kinase inhibitor targeting mast cells and selected kinases, including c-Kit, PDGFR, …
  • PLT Health Solutions Inc:企業の戦略・SWOT・財務分析
    PLT Health Solutions Inc - Strategy, SWOT and Corporate Finance Report Summary PLT Health Solutions Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Spark Infrastructure Group:企業の発電所・SWOT分析2018
    Spark Infrastructure Group - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • Coherus BioSciences Inc (CHRS):企業の財務・戦略的SWOT分析
    Summary Coherus BioSciences Inc (Coherus) is a biosimilar platform company that develops and commercializes biosimilar drugs. The company’s pipeline product candidates include CHS-1701, an pegfilgrastim used to treat febrile neutropenia; CHS-0214, is an etanercept biosimilar candidate which is used …
  • Owen Mumford Ltd:企業の戦略的SWOT分析
    Owen Mumford Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Matthews International Corp (MATW):企業の財務・戦略的SWOT分析
    Matthews International Corp (MATW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Cayenne Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cayenne Medical Inc (Cayenne Medical), a subsidiary of Zimmer Biomet Holdings Inc, is a soft-tissue reconstruction service provider. The company provides knee and shoulder implant products. It offers products such as aperfix femoral, aperfix II tibial, mirror partial knee, cross fix meniscal …
  • International Fibres Group Ltd:企業の戦略的SWOT分析
    International Fibres Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Public Financial Holdings Ltd (626):企業の財務・戦略的SWOT分析
    Public Financial Holdings Ltd (626) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • VolitionRX Ltd (VNRX):医療機器:M&Aディール及び事業提携情報
    Summary VolitionRX Ltd (VolitionRX) is a medical equipment provider that develops diagnostics tests for cancer and other conditions. The company develops Nucleosomics, a platform technology used for measurement and identification of nucleosomes in the blood. It develops tools for the diagnosis of va …
  • IMV Inc (IMV):製薬・医療:M&Aディール及び事業提携情報
    Summary IMV Inc (IMV), formerly Immunovaccine Inc, is a clinical-stage biopharmaceutical company that develops cancer immunotherapies and infectious disease vaccines. The company’s product candidates include DPX-Survivac, a T cell activating immunotherapy that identifies and disrupts cancer biology …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆